XLO earnings: a negative outcome, -13.0%

On November 9, 2023, Xilio Therapeutics, Inc. reached its earnings. The result was a negative outcome, and the stock moved -13.0% in the window around the event. It had already run +16.1% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.